Atlas Trials

Everolimus TDM to Predict Long Term Toxicity

Clinical trial NCT03033186 · UNKNOWN

Trial details

NCT number
NCT03033186
Sponsor
Maastricht University Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine TumourGastrointestinal Neuroendocrine TumourNeuroendocrine Neoplasm of Lung
Start date
2017-05-16
Primary completion
2018-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.